Crossmark

Considering Global Development? Insights from Applications for FDA Breakthrough Therapy and EMA PRIME Designations

Published Online: 2022-10-28

Published Print: 2023-03

Authors

Hanaizi, Zahra

Kweder, Sandra

Thor, Shannon

Ribeiro, Sonia

Marcal, Anabela
License Information

Text and Data Mining valid from 2022-10-28

Version of Record valid from 2022-10-28
More Information

Article History

Received: 29 July 2022

Accepted: 14 October 2022

First Online: 28 October 2022

Declarations

:

: The authors declared no competing interests for this work.

Document is current